Working to Fight Alzheimer’s Disease Together
The Alzheimer’s Treatment Foundation’s mission is to provide funding directly to Alzheimer’s and Dementia patients seeking treatment. Since many of the specialized procedures to treat Alzheimer’s patients are not covered by insurance, our goal is to see that no patient goes without treatment because they cannot afford it. The Alzheimer’s Treatment Foundation has permanent 501(c)3 status (Federal Tax ID #99-4118324)
Hug The World
Benefit for Alzheimer’s Treatment Foudnation
Special thanks to all who made this years celebration such a fun and successful event. We raised a glass (and much needed money!) to futher our mission of getting those in need of care, the best care available.
Our Mission
To ensure that no patient goes without treatment for Alzheimer’s Disease and/or dementia simply because they cannot afford it. We also hope to rekindle the patient’s and their family’s lost hope.
Fighting Alzheimers, one patient at a time
Americans with Alzheimer's Disease
Average annual cost of treatment
average yearly out-of-pocket expenses
What We Do
The Alzheimer’s Treatment Foundation is a leading independent non-profit dedicated to improving access to treatment for Alzheimer’s disease, dementia and Brain Fog from Long COVID for America’s underinsured. When health insurance is not enough, we fill the gap by assisting with copays, premiums, deductibles and out-of-pocket expenses.
The Alzheimer’s Treatment Foundation awards grants through our designated funds to help patients afford essential treatments, state-of-the-art modalities, nutraceuticals and amazing pharmaceutical medications.
Real Money Helping Real Patients
The financial barriers for underinsured patients seeking treatment of Alzheimer’s and dementia is a very real struggle. We want to build a bridge for these patients by raising money that creates access to state-of-the-art Artificial Intelligence (AI) + Personalized Precision Medicine. Proceeds also subsidize the “cash portion” of the cost of treatments for patients who could not afford it.
By 2050 it is estimated that 23 million Americans will have Alzheimer’s, more than triple the cases today.
This isn’t something we can put off – your donation today can make a difference in many lives of patients and their families.
FAQs
How does the Alzheimer’s Treatment Foundation support Alzheimer’s?
The Foundation is committed to supporting future research, clinical trials, and projects that advance the treatment, understanding, and prevention of Alzheimer’s among people aged 50 and younger. Additionally, we support efforts to build and grow the pipeline of future leaders by encouraging medical students and emerging professionals to focus on functional medicine, Alzheimer’s, and cognitive health. Volunteers are also needed for clinical trials to advance current research.
Who is most at risk for Alzheimer’s, and what are the risk factors?
African Americans face higher risks due to factors like high blood pressure, high cholesterol, diabetes, and education quality.
What is the Foundation doing to change public perception of Alzheimer's?
We aim to increase awareness, end stigma, and promote brain-healthy living through events, making our brand synonymous with Alzheimer’s treatment and prevention.
How is the Foundation addressing the shortage of dementia researchers?
We support building a pipeline of future leaders, encouraging medical students and emerging professionals to specialize in dementia and cognitive health.
Clinical Partners
The Alzheimer’s Treatment Foundation partners with Alzheimer’s treatment and research facilities to advance care for cognitive conditions, including Alzheimer’s and dementia. These partners use artificial intelligence and precision medicine to identify root causes of cognitive decline. Their protocols have shown success, with 75% of mild cognitive impairment patients experiencing no further decline. This partnership helps the foundation’s mission to improve outcomes for those affected by Alzheimer’s.
Board of Directors
Ronald F. Buckley
Board Chairman, President
Ronald F. Buckley, Chairman and President of the Alzheimer’s Treatment Foundation, brings over 30 years of experience as a real estate developer, licensed real estate broker, and general contractor. He has managed development projects valued at over $1 billion, including student housing, mixed-use town centers, and marina developments. As founder of multiple successful ventures, including Intergroup Realty and Trident Realty, Mr. Buckley has developed thousands of residential units and award-winning historic preservation projects. A U.S. Naval Officer and University of Detroit graduate, he holds active Florida licenses as a general contractor and real estate broker.
Dr Viktor Bouquette
Board Member
Dr. Bouquette, a board member of the Alzheimer’s Treatment Foundation, has a distinguished background in Emergency Medicine and integrative care. Named 1994 Physician of the Year at Rockdale Medical Center in Conyers, GA, he has researched the impact of nutritional deficiencies, metabolic imbalances, and environmental toxins on the immune system. A member of the American College of Environmental Medicine and a certified IAQA mold remediator, Dr. Bouquette combines expertise in environmental, traditional, and alternative medicine. He earned his medical degree from Ohio State University and completed his internship at Emory University.
H. Allen Samuels
Board Member, Secretary / Treasurer
H. Allen Samuels, a Florida Certified Public Accountant, serves as Secretary/Treasurer and a board member for the Alzheimer’s Treatment Foundation, contributing his extensive financial expertise to support the organization’s mission. Throughout his career, he has held key leadership roles, including Controller for a major student housing developer managing over 10,000 beds, CFO of a $200 million mixed-use and condominium developer, and CFO of a local insurance agency generating $10 million in annual revenue. His deep knowledge of financial management and strategic planning makes him a valuable asset to the foundation and its work.
Advisory Board
Alfred Zaccagnino
The Samarian Group
Kristin Bentz
Former host of The Street on CNBC
Patrice Samara
the Founder & President of Triumph Communications Group and COO of Wordeee
Phil Vassar
Legendary Singer/Songwriter
Rowena Poitier Sutherland
Former Minister of Culture for the Bahamas
Tim Loudermilk
prominent Entertainment Attorney
Hala Moddelmog
Corporate Director of FLEETCOR Technologies and Director of Lamb Weston
Michael Parker
Publisher/CEO of Wordcrafts Press
Matt George
Big Brand Ventures, CEO of The Harrington Foundation, Harvard Business School Executive Leadership Coach
Tony Sun
Former CEO of Venrock, the Rockefeller Family Venture Fund
Tom Heshion
Arizona Mountain Vinyards, Founder and CEO Auto-by-Tel.com